FDA Approves XOCOVA — Shionogi Inc.
Shionogi Inc. announced FDA approval for the oral antiviral XOCOVA (ensitrelvir) effective May 29, positioning the company to expand its commercial footprint with a non-injectable alternative expected to capture share among patient populations seeking convenient dosing.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day